No Need to Sugarcoat the Message: Is Cardiovascular Risk Reduction From SGLT2 Inhibition Related to Natriuresis?
Am J Kidney Dis
.
2016 Sep;68(3):349-52.
doi: 10.1053/j.ajkd.2016.03.410.
Epub 2016 Mar 30.
Authors
Bruce A Perkins
1
,
Jacob A Udell
1
,
David Z I Cherney
2
Affiliations
1
University of Toronto, Ontario, Canada.
2
University of Toronto, Ontario, Canada. Electronic address: david.cherney@uhn.ca.
PMID:
27039253
DOI:
10.1053/j.ajkd.2016.03.410
No abstract available
Publication types
Editorial
Comment
MeSH terms
Cardiovascular Diseases*
Humans
Hypoglycemic Agents
Natriuresis / drug effects*
Risk Factors
Sodium-Glucose Transporter 2
Substances
Hypoglycemic Agents
Sodium-Glucose Transporter 2